Although further studies will be needed to identify relative representation of T cells specific for individual peptides, and to determine whether immunodominance might occur, the finding that peptide-specific T cell responses are enriched in tumor-rejecting mice support acquired antigenicity and immunogenicity of Mlh1-/- tumors. This evidence concerns the gene MLH1 and neoplasm.